What is Henry Schein?
Founded in 1932 and headquartered in Melville, New York, Henry Schein operates as a critical infrastructure provider for dental practitioners, physician practices, and ambulatory surgery centers worldwide. The company's business model is bifurcated into a robust distribution network—supplying everything from pharmaceuticals and vaccines to high-tech digital restoration equipment—and a sophisticated Technology and Value-Added Services division. This latter segment provides essential practice management software, revenue cycle management, and consulting services, effectively creating a comprehensive ecosystem that supports the operational efficiency of healthcare providers globally. As a long-standing industry incumbent, Henry Schein maintains a dominant footprint in the alternate care market, consistently adapting its service portfolio to meet the evolving demands of modern clinical environments.
How much funding has Henry Schein raised?
Henry Schein has raised a total of $322.8M across 3 funding rounds:
Stock Offering
$72.8M
Debt
$12K
Other Financing Round
$250M
Stock Issuance/Offering (1995): $72.8M, investors not publicly disclosed
Debt (2024): $12K led by Central Pacific Bank
Other Financing Round (2025): $250M supported by KKR
Key Investors in Henry Schein
KKR
KKR is a global investment firm investing across private markets in every asset class all over the world, KKR mission is to fortify companies and communities and help secure the futures of the institutions and individuals counting on us.
Central Pacific Bank
A regional financial institution providing commercial banking services and debt financing solutions to support corporate growth and operational liquidity.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Henry Schein?
With the recent capital deployment, Henry Schein is positioned to deepen its investment in high-growth areas such as practice automation and advanced diagnostic technologies. The strategic nature of this financing suggests a focus on long-term value creation, likely involving the expansion of its digital service offerings and the optimization of its global supply chain logistics. As the healthcare sector continues to prioritize integrated, technology-driven care, Henry Schein's ability to leverage its extensive distribution network alongside its software capabilities will be pivotal. Investors and market analysts will be monitoring how the firm utilizes this capital to navigate competitive pressures and maintain its trajectory of sustainable growth in an increasingly digitized healthcare landscape.
See full Henry Schein company page
